DSC
ABMD

Duncker Streett & Co’s Abiomed Inc ABMD Stock Holding History

Duncker Streett & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-175
Closed -$33K – 609
2017
Q4 		$33K Sell
175
-175
-50% -$32.7K 0.01% 431
2017
Q3 		$59K Buy
350
+100
+40% +$15.1K 0.02% 366
2017
Q2 		$36K Buy
+250
New +$33.6K 0.01% 416
2016
Q1 		– Sell
-300
Closed -$27K – 639
2015
Q4 		$27K Hold
300
– – 0.01% 421
2015
Q3 		$28K Buy
+300
New +$26.4K 0.01% 416

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Duncker Streett & Co's ABMD Position: Q1 2018 in Review

Duncker Streett & Co sold out of Abiomed Inc (ABMD) in Q1 2018, closing a stake of 175 shares — an estimated $33K sold.

Duncker Streett & Co first reported a position in ABMD in Q3 2015 and held it in 5 quarters. The position peaked at $59K in Q3 2017. 405 funds tracked by Wall St. Rank hold ABMD as of Q1 2018.

  • Duncker Streett & Co reported no remaining Abiomed Inc position as of Q1 2018 after selling out during the quarter.
  • Duncker Streett & Co sold 175 Abiomed Inc shares in Q1 2018, an estimated $33K.
  • Duncker Streett & Co first reported a position in Abiomed Inc in Q3 2015 and held it in 5 quarters.
  • Duncker Streett & Co's Abiomed Inc position peaked at $59K in Q3 2017.
  • 405 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2018.

Based on Duncker Streett & Co's 13F filing for Q1 2018, filed 26 Apr 2018.